Neuragenex Neurofunctional Pain Management

What Neuragenex Neurofunctional Pain Management does

Neuragenex Neurofunctional Pain Management (NFPM), founded in 2017 and headquartered in Mesa, Arizona, operates a proprietary, FDA-cleared chronic pain treatment program delivered entirely through a mobile, at-home care model. The protocol is non-pharmaceutical, non-surgical, non-invasive, and non-chiropractic, and combines electroanalgesia (electrical stimulation therapy), IV therapy, lifestyle counseling, and — for chronic knee pain — TriVisc viscosupplementation injections. Treatments are administered by board-certified providers after a telehealth intake, with care delivered to the patient's home across 30+ U.S. states, backed by staffed offices in Denver, Chicago, Atlanta, San Antonio, Tucson, Madison, and Milwaukee.

The company is operated through the RELATYV platform, which also hosts complementary service lines including Neurassage (massage therapy) and Mobile Allergy Treatment, allowing neuragenex to extend the same mobile delivery chassis into adjacent verticals. Pricing is not publicly disclosed; the company accepts Medicare and all major insurance plans and offers financing, with revenue generated through direct-to-consumer chronic pain treatment services on a recurring treatment-program basis. Founder Will Bozeman leads the company, and the company claims to have treated thousands of patients, with over 85% reporting a 50% or greater reduction in pain.

Customer acquisition is primarily direct-to-consumer, supported by provider referrals, content marketing, and patient education resources. No institutional funding, no M&A activity, no disclosed partnerships, and no AI/ML capabilities are present in the source material, placing Neuragenex as an early-stage, privately held, clinically focused healthcare services company whose strategic moat rests on its FDA-cleared protocol and its differentiated mobile at-home distribution model.

Name

Neuragenex Neurofunctional Pain Management

Legal name

Neuragenex Neurofunctional Pain Management

Website

https://neuragenex.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Neuragenex Neurofunctional Pain Management (NFPM) is a Mesa, Arizona-based, privately held healthcare company that delivers a proprietary, FDA-cleared, non-drug, non-surgical chronic pain treatment program via mobile, at-home visits in 30+ U.S. states, accepting Medicare and all major insurances.

Ownership category

akta.pro rank

Product category

Pain Management Services

NAICS

Health Care and Social Assistance (62)

SIC

Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAKAIAM

Pain Medicine (Interventional/Neuropathic Pain)

Healthcare & Life Sciences/Specialist Medical Practice/Neurology

Keywords

• Chronic pain treatment
• Neurofunctional pain management
• Electroanalgesia therapy
• Mobile pain management
• Non-opioid pain relief

Headquarters

HQ city

Denver

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Pain Treatment Services: Direct patient treatment services for chronic pain conditions using NFPM protocol

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Neuragenex provides non-opioid, non-surgical chronic pain management through a proprietary Neurofunctional Pain Management (NFPM) protocol, delivered via in-person clinics and a mobile at-home treatment model. Its core services center on FDA-cleared electroanalgesia therapy, supplemented by IV therapy and lifestyle counseling, and the company accepts Medicare and all insurances across 30+ U.S. states.

Product overview

Neuragenex Neurofunctional Pain Management (NFPM) operates as a multi-product healthcare platform offering a core pain management program alongside complementary services. The primary offering is the FDA-cleared Neuragenex NFPM program—a non-drug, non-surgical, non-invasive neurofunctional pain management system delivered 100% at-home via mobile board-certified providers. Supporting products include Neurassage (massage therapy), Mobile Allergy Treatment (allergy services), and specific treatment modalities such as Electroanalgesia, IV Therapy, Lifestyle Counseling, and TriVisc Injections. The company serves patients across multiple U.S. states including Colorado, Wisconsin, Georgia, Texas, Illinois, and Arizona.

Differentiator

Problem solved

Functional benefit

Brands

• Neurofunctional Pain Management: The core treatment program utilizing medical therapies for chronic pain relief without drugs, surgery, or chiropractic interventions

Products and services

• Neurofunctional Pain Management (NFPM) Treatment Program Comprehensive chronic pain treatment program built on Neuragenex's proprietary, FDA-cleared NFPM protocol, designed for adults suffering from chronic pain who want non-opioid, non-surgical alternatives.
• Electroanalgesia Therapy FDA-cleared electrical stimulation therapy used to deliver the NFPM protocol for chronic pain relief, delivered in-clinic or via mobile at-home visits.
• IV Therapy Intravenous therapy administered as part of the NFPM treatment program to support chronic pain management alongside electroanalgesia and lifestyle counseling.
• Lifestyle Counseling Counseling service addressing lifestyle factors that contribute to chronic pain, provided as a component of the NFPM program alongside electroanalgesia and IV therapy.
• Mobile At-Home Pain Treatment Mobile, in-home delivery of the NFPM protocol for chronic pain patients who cannot easily access a physical clinic, extending coverage to 30+ U.S. states.

Quantifiable outcome

• 85%+ of patients experience 50% or more reduction in pain

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Sword Health: Digital MSK and pain management company providing AI-guided virtual physical therapy for chronic pain conditions. Comparable to Neuragenex in addressing chronic pain patients with a non-invasive, non-opioid approach reimbursed by payers and employers.
• Kaia Health: App-based digital pain management platform offering exercise therapy, education, and coaching for MSK and chronic pain. Comparable to Neuragenex in targeting chronic pain patients with non-pharmaceutical self-management alternatives covered by insurance and employers.
• Hinge Health: Digital musculoskeletal and chronic pain platform offering virtual exercise therapy, coaching, and education for back, joint, and nerve pain. Direct peer to Neuragenex as both target chronic pain patients seeking non-opioid, non-surgical, insurance-covered treatment through a tech-enabled care model.

Broad incumbents

• National Spine & Pain Centers: Large US network of interventional pain management clinics providing injections, nerve blocks, and other procedures for chronic pain. Comparable to Neuragenex in targeting chronic pain patients with non-opioid interventional therapies, though delivered in clinic settings rather than mobile at-home.
• CenterWell Home Health (Kindred at Home): National home health agency operated by Humana delivering skilled nursing and rehabilitation services to patients at home. Comparable to Neuragenex on the mobile in-home care delivery model and Medicare-covered home-based services for chronic populations.
• Amedisys: Large US home health services provider delivering skilled nursing, therapy, and chronic care management in patients' homes. Comparable to Neuragenex on the at-home care delivery model, Medicare reimbursement infrastructure, and chronic-condition patient focus.
• Option Care Health: Leading US provider of home and alternate-site infusion therapy, delivering IV treatments to patient homes. Comparable to Neuragenex on the in-home IV therapy component of NFPM and on Medicare/commercial insurance reimbursement for chronic-condition care.
• Agilon Health: Value-based healthcare company partnering with primary care physicians to manage Medicare Advantage seniors with chronic conditions. Comparable to Neuragenex in serving chronic-condition Medicare-covered populations and leveraging value-based care economics for chronic pain management.

Emerging players

• Sprinter Health: Tech-enabled in-home healthcare provider delivering diagnostics, vitals checks, and care services to homebound patients. Comparable to Neuragenex on the mobile at-home delivery infrastructure serving chronic-condition patients who cannot easily access clinic-based care.
• DispatchHealth: Tech-enabled in-home acute and urgent care provider sending medical teams to patient homes. Comparable to Neuragenex on the mobile at-home healthcare delivery model and focus on serving chronic and mobility-limited patients outside traditional clinics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/neuragenex

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuragenex Neurofunctional Pain Management